GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

INR 2852.8

(-3.77%)

Gross Profit Summary of GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited's latest annual gross profit in 2023 was 12.82 Billion INR , down -34.85% from previous year.
GlaxoSmithKline Pharmaceuticals Limited's latest quarterly gross profit in 2024 Q2 was 6.26 Billion INR , up 30.43% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported a annual gross profit of 19.66 Billion INR in annual gross profit 2022, up 7.57% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported a annual gross profit of 18.28 Billion INR in annual gross profit 2021, up 1.34% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported a quarterly gross profit of 6.26 Billion INR for 2024 Q2, up 30.43% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported a quarterly gross profit of 4.88 Billion INR for 2023 Q3, down -18.94% from previous quarter.

Annual Gross Profit Chart of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Historical Annual Gross Profit of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Year	Gross Profit	Gross Profit Growth
2023	12.82 Billion INR	-34.85%
2022	19.66 Billion INR	7.57%
2021	18.28 Billion INR	1.34%
2020	18.04 Billion INR	-1.24%
2019	18.26 Billion INR	8.51%
2018	16.83 Billion INR	9.07%
2017	15.43 Billion INR	8.19%
2016	14.26 Billion INR	-0.23%
2015	14.3 Billion INR	1.22%
2014	14.12 Billion INR	6.59%
2013	13.25 Billion INR	-11.48%
2012	14.97 Billion INR	2.62%
2011	14.59 Billion INR	7.06%
2010	13.62 Billion INR	13.05%
2009	12.05 Billion INR	16.19%
2008	10.37 Billion INR	6.8%
2007	9.71 Billion INR	2.22%
2006	9.5 Billion INR	8.06%
2005	8.79 Billion INR	9.11%
2004	8.06 Billion INR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	3.51 Billion INR	-5.39%
2024 Q2	6.26 Billion INR	30.43%
2023 Q3	4.88 Billion INR	-18.94%
2023 FY	12.81 Billion INR	-34.85%
2023 Q4	3.71 Billion INR	-23.89%
2023 Q1	4.65 Billion INR	5.17%
2023 Q2	6.02 Billion INR	29.43%
2022 FY	19.66 Billion INR	7.57%
2022 Q2	5.51 Billion INR	20.42%
2022 Q1	4.58 Billion INR	25.6%
2022 Q3	5.14 Billion INR	-6.81%
2022 Q4	4.42 Billion INR	-13.92%
2021 Q4	3.64 Billion INR	-26.41%
2021 Q1	4.79 Billion INR	21.45%
2021 FY	18.28 Billion INR	1.34%
2021 Q2	6.06 Billion INR	26.44%
2021 Q3	4.95 Billion INR	-18.29%
2020 Q1	3.91 Billion INR	-3.79%
2020 FY	18.04 Billion INR	-1.24%
2020 Q4	3.95 Billion INR	-21.9%
2020 Q3	5.05 Billion INR	-1.15%
2020 Q2	5.11 Billion INR	30.82%
2019 Q3	4.5 Billion INR	-11.97%
2019 FY	18.26 Billion INR	8.51%
2019 Q4	4.06 Billion INR	-9.8%
2019 Q1	4.57 Billion INR	27.27%
2019 Q2	5.12 Billion INR	12.02%
2018 Q2	4.67 Billion INR	11.53%
2018 FY	16.83 Billion INR	9.07%
2018 Q4	3.59 Billion INR	-18.87%
2018 Q3	4.42 Billion INR	-5.23%
2018 Q1	4.18 Billion INR	0.0%
2017 FY	15.43 Billion INR	8.19%
2017 Q1	3.11 Billion INR	0.0%
2016 FY	14.26 Billion INR	-0.23%
2015 FY	14.3 Billion INR	1.22%
2014 FY	14.12 Billion INR	6.59%
2013 FY	13.25 Billion INR	-11.48%
2012 FY	14.97 Billion INR	2.62%
2011 FY	14.59 Billion INR	7.06%
2010 FY	13.62 Billion INR	13.05%
2009 FY	12.05 Billion INR	16.19%
2008 FY	10.37 Billion INR	6.8%
2007 FY	9.71 Billion INR	2.22%
2006 FY	9.5 Billion INR	8.06%
2005 FY	8.79 Billion INR	9.11%
2004 FY	8.06 Billion INR	0.0%

Peer Gross Profit Comparison of GlaxoSmithKline Pharmaceuticals Limited

Name	Gross Profit	Gross Profit Difference
Abbott India Limited	26.16 Billion INR	51.004%
Cipla Limited	161.81 Billion INR	92.077%
Gland Pharma Limited	16.6 Billion INR	22.779%
Kopran Limited	2.12 Billion INR	-502.865%
Marksans Pharma Limited	7.71 Billion INR	-66.198%
NGL Fine-Chem Limited	1.23 Billion INR	-940.224%
Pfizer Limited	9.9 Billion INR	-29.428%
Sanofi India Limited	16.32 Billion INR	21.47%
SMS Pharmaceuticals Limited	2.1 Billion INR	-507.774%
TTK Healthcare Limited	2.68 Billion INR	-377.215%